Item 2.01 - Completion of Acquisition or Disposition of Assets.
As previously disclosed on July 9, 2018, Bovie Medical Corporation (the Company) entered into an Asset Purchase Agreement (the Purchase Agreement) with Specialty Surgical Instrumentation Inc., a Tennessee corporation (Buyer) and a wholly-owned subsidiary of Symmetry Surgical Inc., a Delaware corporation, providing for the sale by the Company of its electrosurgical Core business segment and related intellectual property, including the Bovie brand, to Buyer for gross proceeds of $97 million in cash (the Asset Sale Transaction).

brand, to Buyer for gross proceeds of $97 million in cash (the Asset Sale Transaction).
The Asset Sale Transaction was consummated in accordance with the terms of the Purchase Agreement on August 30, 2018 (the Closing Date). Pursuant to the terms of the Purchase Agreement, Buyer paid the Company gross proceeds of $97 million in cash.
The foregoing summary of the Purchase Agreement is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, a copy of which was filed as Exhibit 2.1 to the Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the SEC) by the Company on July 9, 2018, and which is incorporated by reference herein.
Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Directors; Compensatory Arrangements of Certain Officers.
